396 related articles for article (PubMed ID: 25966666)
1. Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
Hossain A; Gumin J; Gao F; Figueroa J; Shinojima N; Takezaki T; Priebe W; Villarreal D; Kang SG; Joyce C; Sulman E; Wang Q; Marini FC; Andreeff M; Colman H; Lang FF
Stem Cells; 2015 Aug; 33(8):2400-15. PubMed ID: 25966666
[TBL] [Abstract][Full Text] [Related]
2. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
3. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
4. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
Shahar T; Rozovski U; Hess KR; Hossain A; Gumin J; Gao F; Fuller GN; Goodman L; Sulman EP; Lang FF
Neuro Oncol; 2017 May; 19(5):660-668. PubMed ID: 28453745
[TBL] [Abstract][Full Text] [Related]
5. CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity.
Filppu P; Tanjore Ramanathan J; Granberg KJ; Gucciardo E; Haapasalo H; Lehti K; Nykter M; Le Joncour V; Laakkonen P
JCI Insight; 2021 May; 6(9):. PubMed ID: 33986188
[TBL] [Abstract][Full Text] [Related]
6. Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587.
Figueroa J; Phillips LM; Shahar T; Hossain A; Gumin J; Kim H; Bean AJ; Calin GA; Fueyo J; Walters ET; Kalluri R; Verhaak RG; Lang FF
Cancer Res; 2017 Nov; 77(21):5808-5819. PubMed ID: 28855213
[TBL] [Abstract][Full Text] [Related]
7. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
9. Potential functions and therapeutic implications of glioma-resident mesenchymal stem cells.
Zhang Q; Wang J; Zhang J; Liu F
Cell Biol Toxicol; 2023 Jun; 39(3):853-866. PubMed ID: 37138122
[TBL] [Abstract][Full Text] [Related]
10. The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas.
Zhu XY; Wang L; Luan SH; Zhang HS; Huang WT; Wang NH
Neoplasma; 2014; 61(4):401-10. PubMed ID: 24645841
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
[TBL] [Abstract][Full Text] [Related]
12. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
13. Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts.
Pacioni S; D'Alessandris QG; Giannetti S; Morgante L; Coccè V; Bonomi A; Buccarelli M; Pascucci L; Alessandri G; Pessina A; Ricci-Vitiani L; Falchetti ML; Pallini R
Stem Cell Res Ther; 2017 Mar; 8(1):53. PubMed ID: 28279193
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.
Natesh K; Bhosale D; Desai A; Chandrika G; Pujari R; Jagtap J; Chugh A; Ranade D; Shastry P
Neoplasia; 2015 Feb; 17(2):225-37. PubMed ID: 25748242
[TBL] [Abstract][Full Text] [Related]
15. Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal.
Parajuli P; Anand R; Mandalaparty C; Suryadevara R; Sriranga PU; Michelhaugh SK; Cazacu S; Finniss S; Thakur A; Lum LG; Schalk D; Brodie C; Mittal S
Oncotarget; 2016 Feb; 7(5):6121-35. PubMed ID: 26755664
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.
Cui X; Liu J; Bai L; Tian J; Zhu J
Cancer Sci; 2014 Jan; 105(1):64-71. PubMed ID: 24168060
[TBL] [Abstract][Full Text] [Related]
17. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
Shi Y; Guryanova OA; Zhou W; Liu C; Huang Z; Fang X; Wang X; Chen C; Wu Q; He Z; Wang W; Zhang W; Jiang T; Liu Q; Chen Y; Wang W; Wu J; Kim L; Gimple RC; Feng H; Kung HF; Yu JS; Rich JN; Ping YF; Bian XW; Bao S
Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848664
[TBL] [Abstract][Full Text] [Related]
18. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
Wang H; Lathia JD; Wu Q; Wang J; Li Z; Heddleston JM; Eyler CE; Elderbroom J; Gallagher J; Schuschu J; MacSwords J; Cao Y; McLendon RE; Wang XF; Hjelmeland AB; Rich JN
Stem Cells; 2009 Oct; 27(10):2393-404. PubMed ID: 19658188
[TBL] [Abstract][Full Text] [Related]
19. Mast cells modulate proliferation, migration and stemness of glioma cells through downregulation of GSK3β expression and inhibition of STAT3 activation.
Attarha S; Roy A; Westermark B; Tchougounova E
Cell Signal; 2017 Sep; 37():81-92. PubMed ID: 28600192
[TBL] [Abstract][Full Text] [Related]
20. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]